Radiopharmaceutical Therapy
portes grátis
Radiopharmaceutical Therapy
Zeglis, Brian; Bodei, Lisa; Lewis, Jason S.
Springer International Publishing AG
10/2024
Mole
Inglês
9783031397721
Pré-lançamento - envio 15 a 20 dias após a sua edição
Descrição não disponível.
Preface
Foreword
Section 1. Fundamentals
Chapter 1. Introduction: The Case for Endoradiotherapy
Chapter 2. The History of Endoradiotherapy
Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides
Chapter 4. The Production of Therapeutic Radionuclides
Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons
Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides
Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides
Chapter 8. Dosimetry in Endoradiotherapy
Section 2. Deeper Dives
9. Antibodies as Vectors for Endoradiotherapy
Chapter 10. Case Study #1: 225Ac-Labeled IgG
Chapter 11. Case Study #2: 131I-3F8
Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy
Chapter 13. Peptides as Vectors for Endoradiotherapy
Chapter 14. Case Study #4: LUTATHERA
Chapter 15. Case Study #5: CXCR4
Chapter 16. Case Study #6: JR11
Chapter 17. Small Molecules as Vectors for Endoradiotherapy
Chapter 18. Case Study #7: PSMA-617
Chapter 19. Case Study #8: 223RaCl3
Section 3. Special Topics
Chapter 20. Auger Emitters in Endoradiotherapy
Chapter 21. In Vivo Pretargeting
Chapter 22. Theranostic Imaging and Endoradiotherapy
Chapter 23. The Next Generation of Therapeutic Radionuclides
Chapter 24. Artificial Intelligence and Machine Learning
Chapter 25. The Regulatory Review of Radiotherapeutics: USA
Chapter 26. The Regulatory Review of Radiotherapeutics: Europe
Chapter 27. The Regulatory Review of Radiotherapeutics: Japan
Chapter 28. Radiotherapeutics in the Nuclear Pharmacy
Chapter 29. The Future
Foreword
Section 1. Fundamentals
Chapter 1. Introduction: The Case for Endoradiotherapy
Chapter 2. The History of Endoradiotherapy
Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides
Chapter 4. The Production of Therapeutic Radionuclides
Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons
Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides
Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides
Chapter 8. Dosimetry in Endoradiotherapy
Section 2. Deeper Dives
9. Antibodies as Vectors for Endoradiotherapy
Chapter 10. Case Study #1: 225Ac-Labeled IgG
Chapter 11. Case Study #2: 131I-3F8
Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy
Chapter 13. Peptides as Vectors for Endoradiotherapy
Chapter 14. Case Study #4: LUTATHERA
Chapter 15. Case Study #5: CXCR4
Chapter 16. Case Study #6: JR11
Chapter 17. Small Molecules as Vectors for Endoradiotherapy
Chapter 18. Case Study #7: PSMA-617
Chapter 19. Case Study #8: 223RaCl3
Section 3. Special Topics
Chapter 20. Auger Emitters in Endoradiotherapy
Chapter 21. In Vivo Pretargeting
Chapter 22. Theranostic Imaging and Endoradiotherapy
Chapter 23. The Next Generation of Therapeutic Radionuclides
Chapter 24. Artificial Intelligence and Machine Learning
Chapter 25. The Regulatory Review of Radiotherapeutics: USA
Chapter 26. The Regulatory Review of Radiotherapeutics: Europe
Chapter 27. The Regulatory Review of Radiotherapeutics: Japan
Chapter 28. Radiotherapeutics in the Nuclear Pharmacy
Chapter 29. The Future
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
radiotherapy;cancer therapy;endoradiotherapy;radiopharmaceutical chemistry;Radiotherapeutics;Radioimmunotherapy;cancer imaging;Radiobiology;Medical physics;biochemistry
Preface
Foreword
Section 1. Fundamentals
Chapter 1. Introduction: The Case for Endoradiotherapy
Chapter 2. The History of Endoradiotherapy
Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides
Chapter 4. The Production of Therapeutic Radionuclides
Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons
Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides
Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides
Chapter 8. Dosimetry in Endoradiotherapy
Section 2. Deeper Dives
9. Antibodies as Vectors for Endoradiotherapy
Chapter 10. Case Study #1: 225Ac-Labeled IgG
Chapter 11. Case Study #2: 131I-3F8
Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy
Chapter 13. Peptides as Vectors for Endoradiotherapy
Chapter 14. Case Study #4: LUTATHERA
Chapter 15. Case Study #5: CXCR4
Chapter 16. Case Study #6: JR11
Chapter 17. Small Molecules as Vectors for Endoradiotherapy
Chapter 18. Case Study #7: PSMA-617
Chapter 19. Case Study #8: 223RaCl3
Section 3. Special Topics
Chapter 20. Auger Emitters in Endoradiotherapy
Chapter 21. In Vivo Pretargeting
Chapter 22. Theranostic Imaging and Endoradiotherapy
Chapter 23. The Next Generation of Therapeutic Radionuclides
Chapter 24. Artificial Intelligence and Machine Learning
Chapter 25. The Regulatory Review of Radiotherapeutics: USA
Chapter 26. The Regulatory Review of Radiotherapeutics: Europe
Chapter 27. The Regulatory Review of Radiotherapeutics: Japan
Chapter 28. Radiotherapeutics in the Nuclear Pharmacy
Chapter 29. The Future
Foreword
Section 1. Fundamentals
Chapter 1. Introduction: The Case for Endoradiotherapy
Chapter 2. The History of Endoradiotherapy
Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides
Chapter 4. The Production of Therapeutic Radionuclides
Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons
Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides
Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides
Chapter 8. Dosimetry in Endoradiotherapy
Section 2. Deeper Dives
9. Antibodies as Vectors for Endoradiotherapy
Chapter 10. Case Study #1: 225Ac-Labeled IgG
Chapter 11. Case Study #2: 131I-3F8
Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy
Chapter 13. Peptides as Vectors for Endoradiotherapy
Chapter 14. Case Study #4: LUTATHERA
Chapter 15. Case Study #5: CXCR4
Chapter 16. Case Study #6: JR11
Chapter 17. Small Molecules as Vectors for Endoradiotherapy
Chapter 18. Case Study #7: PSMA-617
Chapter 19. Case Study #8: 223RaCl3
Section 3. Special Topics
Chapter 20. Auger Emitters in Endoradiotherapy
Chapter 21. In Vivo Pretargeting
Chapter 22. Theranostic Imaging and Endoradiotherapy
Chapter 23. The Next Generation of Therapeutic Radionuclides
Chapter 24. Artificial Intelligence and Machine Learning
Chapter 25. The Regulatory Review of Radiotherapeutics: USA
Chapter 26. The Regulatory Review of Radiotherapeutics: Europe
Chapter 27. The Regulatory Review of Radiotherapeutics: Japan
Chapter 28. Radiotherapeutics in the Nuclear Pharmacy
Chapter 29. The Future
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
